Open access
Open access
Powered by Google Translator Translator

Dermatology

Podcast | Common Skin Complaints in Primary Care.

21 Jul, 2021 | 10:22h | UTC

#285 Common Skin Complaints in Primary Care – The Curbsiders

 


2021 ACR Guideline for the Management of Polyarteritis Nodosa.

13 Jul, 2021 | 09:37h | UTC

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa – Arthritis & Rheumatology

 


Viewpoint | Active surveillance as a management option for low-risk basal cell carcinoma.

15 Jun, 2021 | 08:49h | UTC

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma – JAMA Internal Medicine

 


COVID nails: these changes to your fingernails may show you’ve had coronavirus.

10 Jun, 2021 | 09:42h | UTC

COVID nails: these changes to your fingernails may show you’ve had coronavirus – The Conversation

 


COVID-19 Imaging: What we know now and what remains unknown.

9 Jun, 2021 | 08:27h | UTC

COVID-19 Imaging: What We Know Now and What Remains Unknown – Radiology

 


Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection – there was a significant association between skin rashes and a positive swab test result (odds ratio 1.67).

8 Jun, 2021 | 09:26h | UTC

Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection – British Journal of Dermatology

 


Practice Pointer | Mask related acne (“maskne”) and other facial dermatoses.

8 Jun, 2021 | 09:24h | UTC

Mask related acne (“maskne”) and other facial dermatoses – The BMJ

 

Commentary on Twitter

 


RCT: Among patients with pemphigus vulgaris, rituximab was superior to mycophenolate mofetil in producing sustained complete remission at 52 weeks (40% vs 10%) but was associated with increased risk of serious adverse events (22% vs. 15%).

24 May, 2021 | 08:24h | UTC

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris – New England Journal of Medicine

 


New Google AI tool can help patients identify common skin conditions.

24 May, 2021 | 08:23h | UTC

Using AI to help find answers to common skin conditions – Google

Commentary: Google AI tool can help patients identify skin conditions – BBC

 


Review: Histiocytosis

4 May, 2021 | 08:29h | UTC

Histiocytosis – The Lancet

 


New studies in patients with moderate-to-severe psoriasis show greater skin clearance with Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits both interleukin-17A and interleukin-17F

25 Apr, 2021 | 21:08h | UTC

Study 1: Bimekizumab versus Secukinumab in Plaque Psoriasis – New England Journal of Medicine

Study 2: Bimekizumab versus Adalimumab in Plaque Psoriasis – New England Journal of Medicine

Related studies: Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase trial – The Lancet AND Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial – The Lancet

 


RCT: Atenolol has similar efficacy as propranolol with fewer adverse events in the treatment of problematic infantile hemangiomas

20 Apr, 2021 | 05:32h | UTC

Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 


Diagnosis and management of leukocytoclastic vasculitis

14 Apr, 2021 | 01:26h | UTC

Diagnosis and management of leukocytoclastic vasculitis – Internal and Emergency Medicine

 


Cohort study: Higher cumulative exposure to Thiazide diuretics linked to an increased risk of skin cancer in people older than 65 years

13 Apr, 2021 | 05:08h | UTC

Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study – Canadian Medical Association Journal

Commentaries: Thiazides May Up Risk for Skin Cancer in Older Adults – HealthDay AND Some blood pressure medication linked to higher risk of skin cancer, study finds – CTV News

Related study: Case-Control Study: Possible Association of Hydrochlorothiazide Use and Risk of Melanoma

 


Guidelines of care for the management of actinic keratosis

9 Apr, 2021 | 03:20h | UTC

Guidelines of care for the management of actinic keratosis – Journal of the American Academy of Dermatology

 


RCT: Upadacitinib vs. Adalimumab for Psoriatic Arthritis

5 Apr, 2021 | 00:57h | UTC

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)

 


RCT: Abrocitinib vs. Placebo or Dupilumab for Atopic Dermatitis

26 Mar, 2021 | 08:27h | UTC

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine

 


Systematic review: Interventions for cutaneous disease in systemic lupus erythematosus

17 Mar, 2021 | 02:30h | UTC

Interventions for cutaneous disease in systemic lupus erythematosus – Cochrane Library

 


Clinical Update: Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021

10 Mar, 2021 | 08:14h | UTC

Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021 – JAMA (free for a limited period)

 


Some experience delayed rash after Moderna shot, study says

5 Mar, 2021 | 08:44h | UTC

Some Experience Delayed Rash After Moderna Shot, Study Says – Bloomberg

Original study: Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 – New England Journal of Medicine

 


Expert consensus on practical aspects in the treatment of chronic urticaria

3 Mar, 2021 | 08:28h | UTC

Expert consensus on practical aspects in the treatment of chronic urticaria – Allergo Journal International

 


Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

2 Mar, 2021 | 01:24h | UTC

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Indian Guidelines for pediatric skin care in neonates, infants, and children

28 Feb, 2021 | 20:37h | UTC

Indian Academy of Pediatrics Guidelines for Pediatric Skin Care

 


Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

23 Feb, 2021 | 01:57h | UTC

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C) – Open Forum Infectious Diseases

Commentary: Experts at Children’s Hospital of Philadelphia Describe Types of Rashes Associated with MIS-C – Children’s Hospital of Philadelphia

 


Cohort study: Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures

26 Jan, 2021 | 00:38h | UTC

Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures – JAMA Dermatology

Editorial: Topical Corticosteroids and Glucocorticoid-Induced Osteoporosis—Cumulative Dose and Duration Matter

Commentaries: Prolonged Use of Topical Steroids Associated with Increased Risk of Osteoporosis – Physician’s Weekly AND Potent Topical Corticosteroids Tied to Increased Fracture Risk – NEJM Journal Watch

Author Interview: Association of Topical Corticosteroids and Risk of Osteoporosis and Major Osteoporotic Fractures – JAMA

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.